Leaderboards/glaucoma and retinal disorders

glaucoma and retinal disorders

Last updated June 2, 2026

Rising Stars

New and hot

Rising Stars Researchers

Panagiotis Maghsoudlou

University of Bristol

Andrew D. Dick

University of Bristol

Wenyi Guo

Unknown

Md Najib Hasan

Khulna University of Engineering and Technology

Hui Wang

Queen's University Belfast

S. Vidivelli

SASTRA University

Muhammad Hammad Malik

Beijing Information Science & Technology University

Da‐Wei Ding

Beijing Information Science & Technology University

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

José A. Fernández‐Albarral

Universidad Complutense de Madrid

Morteza Abyadeh

Unknown

Dipankar Das

Malaviya National Institute of Technology Jaipur

Yifei Niu

Second Affiliated Hospital of Zhejiang University

Qiongrong Xia

Unknown

Rumeng Chen

Beijing University of Chinese Medicine

Zhuorong Li

Communication University of Zhejiang

Caiyu Yu

Wenzhou Medical University

Emerging Leaders Papers

Insufficient data

All-Time Leaders

The canon

All-Time Leaders Researchers

George L. King

Brigham and Women's Hospital

Michal Schwartz

Allergan (United States)

Simon W. M. John

Tufts University

Susan E. Quaggin

Northwestern University

Gui‐Shuang Ying

University of Pennsylvania

Unknown

Unknown

Johns Hopkins University

All-Time Leaders Papers

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats

Journal of Clinical Investigation|1999

603 cit.

Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology

Nature Communications|2015

499 cit.

Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction

Nature Medicine|2017

488 cit.

Remote patient monitoring using artificial intelligence: Current state, applications, and challenges

Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery|2023

443 cit.

Direct Demonstration of Separate Receptors for Growth and Metabolic Activities of Insulin and Multiplication-stimulating Activity (an Insulinlike Growth Factor) Using Antibodies to the Insulin Receptor

Journal of Clinical Investigation|1980

346 cit.

RETRACTED ARTICLE: Novel deep genetic ensemble of classifiers for arrhythmia detection using ECG signals

Neural Computing and Applications|2019

248 cit.

PD-1/PD-L1 checkpoint blockade harnesses monocyte-derived macrophages to combat cognitive impairment in a tauopathy mouse model

Nature Communications|2019

216 cit.

Angiopoietin-1 is required for Schlemm’s canal development in mice and humans

Journal of Clinical Investigation|2017

198 cit.

Context-dependent functions of angiopoietin 2 are determined by the endothelial phosphatase VEPTP

Proceedings of the National Academy of Sciences|2018

130 cit.

Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective

Proceedings of the National Academy of Sciences|2017

117 cit.

Reagents for glaucoma and retinal disorders

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Recommended

Best all-around

Cell Signaling Technology

MEIS1/2 Antibody

Cited in 7 papers

#12744$317

View Evidence →Cell Signaling Technology

Phospho-IKK alpha/beta (Ser176/180) (16A6) Rabbit Monoclonal Antibody (PE Conjugate)

Cited in 6 papers

#14938$493

View Evidence →Cell Signaling Technology

SimpleChIP® Human HoxA1 Intron 1 Primers

Cited in 6 papers

#7707$137

View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Phospho-PLC gamma1 (Ser1248) (D25A9) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 12 papers

#16685$898

View Evidence →Cell Signaling Technology

Phospho-NuMA (Thr2055) Antibody

Cited in 9 papers

#14951$362

View Evidence →Cell Signaling Technology

Phospho-RRM2 (Thr33) (F1B6L) Rabbit Monoclonal Antibody

Cited in 8 papers

#72737$176

View Evidence →